Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95/CD95L
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Natural killer (NK) cell activity is more attenuated in hepatocellular carcinoma (HCC) patients than normal. Hypoxic-inducible factor (HIF)-1α is highly expressed in tumors to maintain their metabolism in a hypoxic environment. The expression of HIF-1α in cancers can lead to cell growth, proliferation, invasion/metastasis and immune escape. Although apigenin, a flavonoid, is known to have various biological activities, it has not been demonstrated in NK cell immune activity in HCC cells. In this study, NK-92 cells were directly cocultured with HCC SK-Hep1 cells for 24 h to evaluate NK cell activity in HCC cells or HCC cells expressing HIF-1α by apigenin. NK cell cytotoxicity to HCC cells expressing HIF-1α was significantly increased, and NK cell-activating receptors, NKG2D, NKp30 and NKp44 were highly expressed. The activating effect of apigenin on NK cells substantially induced apoptosis in HCC cells expressing HIF-1α through high expression of CD95L on the surface of NK-92 cells. Moreover, apigenin excellently inhibited the level of TGF-β1 in a coculture of NK cells and HCC cells. In conclusion, apigenin seems to be a good compound that increases NK cell cytotoxicity to HCC cells by controlling HIF-1α expression.
Abstract
Natural killer (NK) cell activity is more attenuated in hepatocellular carcinoma (HCC) patients than normal. Hypoxic-inducible factor (HIF)-1α is highly expressed in tumors to maintain their metabolism in a hypoxic environment. The expression of HIF-1α in cancers can lead to cell growth, proliferation, invasion/metastasis and immune escape. Although apigenin, a flavonoid, is known to have various biological activities, it has not been demonstrated in NK cell immune activity in HCC cells. In this study, NK-92 cells were directly cocultured with HCC SK-Hep1 cells for 24 h to evaluate NK cell activity in HCC cells or HCC cells expressing HIF-1α by apigenin. NK cell cytotoxicity to HCC cells expressing HIF-1α was significantly increased, and NK cell-activating receptors, NKG2D, NKp30 and NKp44 were highly expressed. The activating effect of apigenin on NK cells substantially induced apoptosis in HCC cells expressing HIF-1α through high expression of CD95L on the surface of NK-92 cells. Moreover, apigenin excellently inhibited the level of TGF-β1 in a coculture of NK cells and HCC cells. In conclusion, apigenin seems to be a good compound that increases NK cell cytotoxicity to HCC cells by controlling HIF-1α expression.
참고문헌 (45)
- Hashem B. El-Serag, "Hepatocellular Carcinoma", New England Journal of Medicine, 365(12), pp.1118~1127 (2011), Massachusetts Medical Society[DOI]
- Marengo A, "Liver cancer : Connections with obesity, fatty liver, and cirrhosis", Annu. Rev. Med, 67, pp.103~117 (2016)
- Khemlina G, "The biology of Hepatocellular carcinoma : implications for genomic and immune therapies", Mol. Cancer, 16, pp.149~ (2017)
- Zucman-Rossi J, "Genetic landscape and biomarkers of Hepatocellular Carcinoma", Gastroenterology, 149, pp.1226~1239 (2015)[DOI]
- Helmlinger G, "Interstitial pH and pO2 gradients in solid tumors in vivo : High-resolution measurements reveal a lack of correlation", Nat. Med, 3, pp.177~182 (1997)
- Patrick H Maxwell CWP, "Activation of the HIF pathway in cancer", Curr. Opin. Genet. Dev, 11, pp.293~299 (2001)
- Brahimi-Horn MC, "Oxygen, a source of life and stress", FEBS Lett, 581, pp.3582~3591 (2007)
- MulthoffG, "Hypoxia Compromises anti-cancer immune responses", Adv. Exp. Med. Biol, 1232, pp.131~143 (2020)
- Voskoboinik I, "Perforin and granzymes : function, dysfunction and human pathology", Nat. Rev. Immunol, 15, pp.388~400 (2015)
- Stiglund N, "Retained NK cell phenotype and functionality in nonalcoholic fatty liver disease", Front. Immunol, 10, pp.1255~ (2019)
- Cai L, "Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients", Clin. Immunol, 129, pp.428~437 (2008)
- Prager I, "NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing", J. Exp. Med, 216, pp.2113~2127 (2019)
- Barrow AD, "The natural cytotoxicity receptors in health and disease", Front. Immunol, 10, pp.909~ (2019)
- Peter ME, "The CD95(APO-1", Fas)DISC and beyond, 2003, pp.10, 26~35
- Zsófia Edit Pápay AK, "Study on the pulmonary delivery system of apigenin-loaded albumin nanocarriers with antioxidant activity", J. Aerosol Med. Pulm. Drug Deliv, 30, pp.274~288 (2017)
- Yuan-Chuen Wang K-MH, "In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells", Food Chem. Toxicol, 53, pp.376~383 (2013)
- Berrin Özçelik MK, "Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids", Pharm. Biol, 49, pp.396~402 (2009)
- Yan X, "Apigenin in cancer therapy : anti-cancer effects and mechanisms of action", Cell Biosci, 7, pp.50~ (2017)
- Zhang W, "Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors", PLoS One, 9, pp.e110429~ (2014)
- Aung MOMH, "Effects of apigenin, luteolin, and quercetin on the Natural Killer(NK-92)cells proliferation : A potential role as immunomodulator", Sains Malaysiana, 50, pp.821~828 (2021)
- Oshimi Y, "Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells", J. Immunol, 157, pp.2909~2915 (1996)
- Suda T, "Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family", Cell, 75, pp.1169~1178 (1993)
- Viel S, "TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway", Sci. Signal, 9, pp.ra19~ (2016)
- Pil Soo Sung, "Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications", International Journal of Molecular Sciences, 19(11), pp.3648~ (2018), MDPI AG[DOI]
- Peter Vaupel, "Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response", The Oncologist, 9(S5), pp.4~9 (2004), Oxford University Press (OUP)[DOI]
- Janine T. Erler, "Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance", Molecular and Cellular Biology, 24(7), pp.2875~2889 (2004), Informa UK Limited[DOI]
- Peng XH, "Cross-talk between epidermal growth factor receptor and hypoxiainducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression", J. Biol. Chem, 281, pp.25903~25914 (2006)
- Tao L, "Cancer associated fibroblasts : an essential role in the tumor microenvironment", Oncol. Lett, 14, pp.2611~2620 (2017)
- Trapani JA, "Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo", Curr. Opin. Immunol, 12, pp.323~329 (2000)
- Yadav A, "IL-6 promotes head and neck tumor metastasis by inducing epithelialmesenchymal transition via the JAK-STAT3-SNAIL signaling pathway", Mol. Cancer Res, 9, pp.1658~1667 (2011)
- Braun DA, "Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3(STAT3)activation", J. Biol. Chem, 288, pp.2986~2993 (2013)
- Gao Y, "Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells", Nat. Immunol, 18, pp.1004~1015 (2017)
- Palomares O, "Regulatory T cells and immune regulation of allergic diseases : roles of IL-10 and TGF-β", Genes Immun, 15, pp.511~520 (2014)
- Jelicic K, "The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression", Nat. Immunol, 14, pp.1256~1265 (2013)
- Andrianifahanana M, "IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation : a novel mechanism for IFN-gamma response", Oncogene, 26, pp.7251~7261 (2007)
- Chapela PJ, "Cytokine stimulation of MUC4 expression in human female reproductive tissue carcinoma cell lines and endometrial cancer", J. Cell Biochem, 116, pp.2649~2657 (2015)
- Singh AP, "Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis", Cancer Res, 64, pp.622~630 (2004)
- Singh S, "Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling", Nat. Cell Biol, 22, pp.591~602 (2020)
- Lee HH, "NLRP3 deficiency in hepatocellular carcinoma enhances surveillance of NK-92through a modulation of MICA", B, 2021, pp.22, 9285~
- Hu XY, "5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential(ΔΨm)-mediated apoptosis in hepatocellular carcinoma", Clin. Exp. Pharmacol. Pysiol, 42, pp.146~153 (2015)
- Kilani-Jaziri S, "Flavones induce immunomodulatory and anti-inflammatory effects by activating cellular anti-oxidant activity : a structure-activity relationship study", Tumour Biol, 37, pp.6571~6579 (2016)
- Fang J, "Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression", Carcinogenesis, 28, pp.858~864 (2007)
- Lee YH, "Gain of HIF-1α under normoxia in cancer mediates immune adaptation through the AKT", ERK and VEGFA axes, 2015, pp.21, 1438~1446
- Ou ZL, "Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells : role of circ_0000977", miR-153 axis, 2019, pp.16, 1592~1603
- Melstrom LG, "Apigenin down-regulates theh hypoxia response genes : HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells", J. Surg. Res, 167, pp.173~181 (2011)